113 related articles for article (PubMed ID: 2850191)
1. 'Two-route chemotherapy' using intra-arterial cisplatin and intravenous sodium thiosulfate, its neutralizing agent, for hepatic malignancies.
Abe R; Akiyoshi T; Koba F; Tsuji H; Baba T
Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1671-4. PubMed ID: 2850191
[TBL] [Abstract][Full Text] [Related]
2. [Two routes chemotherapy by CDDP and STS against liver tumor].
Takada K; Takashima S; Nakamura K; Morimoto A; Inoue AM; Fujimoto K; Murata K; Usuki N; Minakuchi K; Onoyama Y
Gan To Kagaku Ryoho; 1991 Jan; 18(1):57-62. PubMed ID: 1846284
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of the effect of cisplatin therapy in unresectable hepatocellular carcinoma].
Matsuki S; Sugimoto M; Nii S; Kokubu S; Yamada N; Ishii K; Shibata H; Okabe H
Gan To Kagaku Ryoho; 1988 Jan; 15(1):53-7. PubMed ID: 2827586
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial cis-platinum infusion with sodium thiosulfate protection and angiotensin II induced hypertension for treatment of hepatocellular carcinoma.
Onohara S; Kobayashi H; Itoh Y; Shinohara S
Acta Radiol; 1988; 29(2):197-202. PubMed ID: 2833919
[TBL] [Abstract][Full Text] [Related]
5. Increased therapeutic effect on metastatic liver tumors in rats of two-route chemotherapy using cis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, with temporary clamping of the abdominal aorta.
Hasuda K; Kobayashi H; Aoki K; Taniguchi S; Baba T
Cancer Chemother Pharmacol; 1990; 26(3):181-7. PubMed ID: 2357764
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of intraarterial cisplatin in humans.
Campbell TN; Howell SB; Pfeifle CE; Wung WE; Bookstein J
J Clin Oncol; 1983 Dec; 1(12):755-62. PubMed ID: 6321676
[TBL] [Abstract][Full Text] [Related]
7. [Intra-arterial infusion through 2 routes in liver (primary and metastatic cancer].
Koba F; Tsuii H; Abe R; Asoh T; Miyazaki S; Shirasaka C; Takeuchi Y; Arinaga S; Wada T; Uchida I; Akiyoshi T; Baba T
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1684-90. PubMed ID: 6683485
[TBL] [Abstract][Full Text] [Related]
8. [Two-route chemotherapy by CDDP and STS in liver metastasis of gastrointestinal adenocarcinoma].
Nojiri O; Nakamura M; Tanaka Y; Banno T
Gan To Kagaku Ryoho; 1988 Jan; 15(1):47-51. PubMed ID: 3337529
[TBL] [Abstract][Full Text] [Related]
9. "Two route infusion chemotherapy" using cis-Diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, for metastatic liver tumors in rats.
Uozumi J; Sagiyama K; Taniguchi S; Iwamoto Y; Aoki K; Baba T
Jpn J Surg; 1982; 12(6):456-62. PubMed ID: 6891949
[TBL] [Abstract][Full Text] [Related]
10. [Two-route chemotherapy under AT-II induced hypertension using totally implanted injection port system in liver metastases derived from digestive cancers].
Hokita S; Takao S; Tokushige M; Maenohara S; Aikou T; Shimazu H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2901-4. PubMed ID: 2782895
[TBL] [Abstract][Full Text] [Related]
11. Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies.
Vexler AM; Mou X; Gabizon AA; Gorodetsky R
Int J Cancer; 1995 Mar; 60(5):611-5. PubMed ID: 7532157
[TBL] [Abstract][Full Text] [Related]
12. High-dose cisplatin with sodium thiosulfate protection.
Pfeifle CE; Howell SB; Felthouse RD; Woliver TB; Andrews PA; Markman M; Murphy MP
J Clin Oncol; 1985 Feb; 3(2):237-44. PubMed ID: 4038510
[TBL] [Abstract][Full Text] [Related]
13. [Two-route chemotherapy using the anticancer drug cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate].
Kuroiwa T; Baba T
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1011-7. PubMed ID: 3566300
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of "two-route chemotherapy" using intra-arterial cisplatin and iv sodium thiosulfate, its antidote, in rat bladder tumor.
Sagiyama K; Uozumi J; Aoki K; Baba T
Cancer Treat Rep; 1983 Jun; 67(6):567-72. PubMed ID: 6305498
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma.
Lin CP; Yu HC; Cheng JS; Lai KH; Lo GH; Hsu PI; Lin CK; Chen HH; Lo CC; Liang HL; Tseng HH
J Chin Med Assoc; 2004 Dec; 67(12):602-10. PubMed ID: 15779483
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma.
Nagai H; Kanayama M; Higami K; Momiyama K; Ikoma A; Okano N; Matsumaru K; Watanabe M; Ishii K; Sumino Y; Miki K
World J Gastroenterol; 2007 Jan; 13(2):280-4. PubMed ID: 17226909
[TBL] [Abstract][Full Text] [Related]
18. Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma.
Poggi G; Montagna B; Melchiorre F; Quaretti P; Delmonte A; Riccardi A; Tagliaferri B; Sottotetti F; Di Cesare P; Stella MG; Villani L; Zorzetto M; Greco G; Cornalba G; Bernardo G
Anticancer Res; 2011 Nov; 31(11):3927-33. PubMed ID: 22110221
[TBL] [Abstract][Full Text] [Related]
19. [Hepatocellular carcinoma treated by continuous hepatic arterial infusion of etoposide, CDDP and 5-FU].
Tarusawa K; Yodono H; Sasaki T; Ikami I; Fujii N; Akimura R; Nakamura Y; Kanehira J; Midorikawa H; Kimura T
Gan To Kagaku Ryoho; 1990 Jan; 17(1):53-8. PubMed ID: 2153370
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal cisplatin with systemic thiosulfate protection.
Howell SB; Pfeifle CL; Wung WE; Olshen RA; Lucas WE; Yon JL; Green M
Ann Intern Med; 1982 Dec; 97(6):845-51. PubMed ID: 6890785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
